Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: An observational and case-control study

The Lancet Infectious Diseases

Volumn 15, Issue 4, 2015, Pages 422-428

  Bar Zeev, Naor ^a,b   Kapanda, Lester ^a   Tate, Jacqueline E ^c   Jere, Khuzwayo C ^a,b   Iturriza Gomara, Miren ^b   Nakagomi, Osamu ^d   Mwansambo, Charles ^e   Costello, Anthony ^f   Parashar, Umesh D ^c   Heyderman, Robert S ^a,g   French, Neil ^a,b   Cunliffe, Nigel A ^b   Beard, James ^f   Crampin, Amelia C ^h,i   King, Carina ^f   Lewycka, Sonia ^j   Mvula, Hazzie ^h   Phiri, Tambosi ^k   Verani, Jennifer R ^l   Whitney, Cynthia G ^l  

^a UNIVERSITY OF MALAWI   (Malawi)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e MINISTRY OF HEALTH   (Malawi)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁱ KARONGA PREVENTION STUDY   (Malawi)

^j UNIVERSITY OF AUCKLAND   (New Zealand)

^k Mai Mwana Project   (Malawi)

^l CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE;

ARTICLE; CHILD HEALTH CARE; CHILD HOSPITALIZATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; GENOTYPE; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALAWI; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; VACCINATION; VIRAL GASTROENTERITIS; VIRUS DETECTION; CASE CONTROL STUDY; FECES; FEMALE; GASTROENTERITIS; IMMUNOLOGY; INCIDENCE; MALE; NEWBORN; PRESCHOOL CHILD; ROTAVIRUS INFECTIONS; TREATMENT OUTCOME; VIROLOGY;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FECES; FEMALE; GASTROENTERITIS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALAWI; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TREATMENT OUTCOME; VACCINES, ATTENUATED;

EID: 84925351380     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)71060-6     Document Type: Article

References (33)

1. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:136-141. for the WHO-coordinated Global Rotavirus Surveillance Network.
2. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010, 362:299-305.
3. Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010, 29:489-494.
4. Gurgel RG, Bohland AK, Vieira SC, et al. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. Gastroenterology 2009, 137:1970-1975.
5. Molto Y, Cortes JE, De Oliveira LH, et al. Reduction of diarrhea-associated hospitalizations among children aged <5 years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 2011, 30:S16-S20.
6. Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 years of age in Mexico. Pediatr Infect Dis J 2011, 30:S11-S15.
7. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011, 30:S56-S60.
8. Yen C, Armero Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011, 30:S6-10.
9. Bayard V, DeAntonio R, Contreras R, et al. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis 2012, 16:e94-e98.
10. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362:289-298.
11. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:606-614.
12. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.
13. Meeting of the immunization Strategic Advisory Group of Experts, April 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009, 84:220-236. WHO.
14. Rotavirus Vaccine Access and Delivery PATH, (accessed July 25, 2014). http://sites.path.org/rotavirusvaccine/.
15. Malawi Statistics UNICEF, (accessed Jan 25, 2014). http://www.unicef.org/infobycountry/malawi_statistics.html.
16. GINI index data table World Bank, (accessed July 25, 2014). http://data.worldbank.org/indicator/SI.POV.GINI.
17. Ruuska T, Vesikari T Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990, 22:259-267.
18. Malawi Integrated guidelines for providing HIV services 2011, Malawi Ministry of Health, Malawi Ministry of Health, Lilongwe.
19. Department of immunizations vaccines and biologicals. A manual of rotavirus detection and characterization methods 2009, Expanded Programme on Immunization, World Health Organization, Geneva.
20. Malawi census of population and housing 2008 2009, National Statistics Office, National Statistics Office, Zomba.
21. Pagel C, Prost A, Lewycka S, et al. Intracluster correlation coefficients and coefficients of variation for perinatal outcomes from five cluster-randomised controlled trials in low and middle-income countries: results and methodological implications. Trials 2011, 12:151.
22. Hanquet G, Valenciano M, Simondon F, Moren A Vaccine effects and impact of vaccination programmes in post-licensure studies. Vaccine 2013, 31:5634-5642.
23. Hothorn LA, Vaeth M, Hothorn T Trend tests for the evaluation of exposure-response relationships in epidemiological exposure studies. Epidemiol Perspect Innov 2009, 6:1-10.
24. Groome MJ, Page N, Cortese MM, et al. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study. Lancet Infect Dis 2014, 14:1096-1104.
25. Steele AD, De Vos B, Tumbo J, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine 2010, 28:6542-6548.
26. Cunliffe NA, Ngwira BM, Dove W, et al. Epidemiology of rotavirus infection in children in Blantyre, Malawi, 1997-2007. J Infect Dis 2010, 202(suppl):S168-S174.
27. Turner A, Ngwira B, Witte D, Mwapasa M, Dove W, Cunliffe N Surveillance of rotavirus gastro-enteritis in children in Blantyre, Malawi. Paediatr Int Child Health 2013, 33:42-45.
28. Matthijnssens J, Zeller M, Heylen E, et al. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses. Clin Microbiol Infect 2014, 20:O702-O710. RotaBel study group.
29. Braeckman T, Van Herck K, Meyer N, et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. BMJ 2012, 345:e4752.
30. Steele AD, Neuzil KM, Cunliffe NA, et al. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis 2012, 12:213-220.
31. Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010, 201:363-369.
32. Anderson EJ, Shippee DB, Weinrobe MH, et al. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin Infect Dis 2013, 56:755-760.
33. Lopman BA, Curns AT, Yen C, Parashar UD Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011, 204:980-986.